Join our newsletter
Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CSO, Dr. Annie De Groot.
Is “Artificial” Intelligence an Option for your ADA ?
Is "Artificial" Intelligence an Option for your...
March of the Teenage B Cells
March of the Teenage B Cells BCR are Like...
New Class I Features & the Return of AI / HI
We know, and We Care There is not a lot of room...
Immunoinformatics for Animal Health
Applying Immunoinformatics to Animal Health We...
Even more Fearless in 2025
Even more Fearless in 2025 2024 was a year of...
The Season of Gratitude
Talking out loud to myself (and about 7000...
Setting the Standards for Generics
October is Rocking! Off to Amsterdam and...
Falling Forward: New Leadership, New Tools, New Events
September Falling Forward The Transition...
Immunogenicity Risk Assessment: In Silico, In Vitro, and What’s Next
Immunogenicity Risk Assessment: In Silico, In...
The Time is Now for Tregs!
The Time is Now for Tregs! I spoke at a...
Immunogenicity is Personal
Immunogenicity is Personal The Birds are Coming...
Tregitopes by Another Name?
Tregitopes by Another Name? OK, sometimes, I am...